No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Cytokinetics Analyst Ratings
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $62
Express News | Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Investors Push Cytokinetics (NASDAQ:CYTK) 3.7% Lower This Week, Company's Increasing Losses Might Be to Blame
S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead